Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints

Molecular Immunology

Volumn 54, Issue 2, 2013, Pages 199-207

  Miyamoto, Yoshiaki ^a,b   Uga, Hitoshi ^a   Tanaka, Satoshi ^a   Kadowaki, Masakazu ^a   Ikeda, Masafumi ^a   Saegusa, Jun ^b   Morinobu, Akio ^b   Kumagai, Shunichi ^b,c   Kurata, Hirokazu ^a  

^a SYSMEX CORPORATION   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Shinko Hospital   (Japan)

Author keywords

Cell surface molecules; Helper T cell; Rheumatoid arthritis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; PODOPLANIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; ENTERITIS; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVIUM; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOPHENOTYPING; INFLAMMATORY BOWEL DISEASES; JOINTS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; TH17 CELLS; UP-REGULATION;

MUS;

EID: 84871819532     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.11.013     Document Type: Article

References (54)

1. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature Immunology 2007, 8:639-646.
2. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17. Journal of Biological Chemistry 2003, 278:1910-1914.
3. Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S. Type 17T helper cells-origins, features and possible roles in rheumatic disease. Nature Reviews 2009, 5:325-331.
4. Bertozzi C.C., Schmaier A.A., Mericko P., Hess P.R., Zou Z., Chen M., Chen C.Y., Xu B., Lu M.M., Zhou D., Sebzda E., Santore M.T., Merianos D.J., Stadtfeld M., Flake A.W., Graf T., Skoda R., Maltzman J.S., Koretzky G.A., Kahn M.L. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010, 116:661-670.
5. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
6. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051-1057.
7. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., Ma L., Watowich S.S., Jetten A.M., Tian Q., Dong C. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
8. Dagur P.K., Biancotto A., Wei L., Sen H.N., Yao M., Strober W., Nussenblatt R.B., Philip McCoy J. MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. Journal of Autoimmunity 2011, 37:319-327.
9. Dong C., Flavell R.A. Th1 and Th2 cells. Current Opinion in Hematology 2001, 8:47-51.
10. Ekwall A.K., Eisler T., Anderberg C., Jin C., Karlsson N., Brisslert M., Bokarewa M.I. The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis. Arthritis Research and Therapy 2011, 13:R40.
11. Genovese M.C., Van den Bosch F., Roberson S.A., Bojin S., Biagini I.M., Ryan P., Sloan-Lancaster J. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis and Rheumatism 2010, 62:929-939.
12. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., Ramos H.L., Wei L., Davidson T.S., Bouladoux N., Grainger J.R., Chen Q., Kanno Y., Watford W.T., Sun H.W., Eberl G., Shevach E.M., Belkaid Y., Cua D.J., Chen W., O'Shea J.J. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967-971.
13. Glimcher L.H., Murphy K.M. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes and Development 2000, 14:1693-1711.
14. Hirota K., Hashimoto M., Yoshitomi H., Tanaka S., Nomura T., Yamaguchi T., Iwakura Y., Sakaguchi N., Sakaguchi S. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. Journal of Experimental Medicine 2007, 204:41-47.
15. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., Yamaguchi T., Nomura T., Ito H., Nakamura T., Sakaguchi N., Sakaguchi S. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine 2007, 204:2803-2812.
16. Honma M., Minami-Hori M., Takahashi H., Iizuka H. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-beta and STAT-3 activating cytokines, IFN-gamma, IL-6, and IL-22. Journal of Dermatological Science 2012, 65:134-140.
17. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. Journal of Infectious Diseases 2004, 190:624-631.
18. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., Fujikado N., Tanahashi Y., Akitsu A., Kotaki H., Sudo K., Nakae S., Sasakawa C., Iwakura Y. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30:108-119.
19. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
20. Kagami S., Rizzo H.L., Lee J.J., Koguchi Y., Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. Journal of Investigative Dermatology 2010, 130:1373-1383.
21. Kato Y., Fujita N., Kunita A., Sato S., Kaneko M., Osawa M., Tsuruo T. Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. Journal of Biological Chemistry 2003, 278:51599-51605.
22. Kerrigan A.M., Dennehy K.M., Mourao-Sa D., Faro-Trindade I., Willment J.A., Taylor P.R., Eble J.A., Reis e Sousa C., Brown G.D. CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. Journal of Immunology 2009, 182:4150-4157.
23. Kleinschek M.A., Boniface K., Sadekova S., Grein J., Murphy E.E., Turner S.P., Raskin L., Desai B., Faubion W.A., de Waal Malefyt R., Pierce R.H., McClanahan T., Kastelein R.A. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. Journal of Experimental Medicine 2009, 206:525-534.
24. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annual Review of Immunology 2009, 27:485-517.
25. Kryczek I., Wei S., Vatan L., Escara-Wilke J., Szeliga W., Keller E.T., Zou W. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. Journal of Immunology 2007, 179:1423-1426.
26. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., Shevach E.M., O'Shea J.J. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
27. Leipe J., Grunke M., Dechant C., Reindl C., Kerzendorf U., Schulze-Koops H., Skapenko A. Role of Th17 cells in human autoimmune arthritis. Arthritis and Rheumatism 2010, 62:2876-2885.
28. Leonardi C., Matheson R., Zachariae C., Cameron G., Li L., Edson-Heredia E., Braun D., Banerjee S. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. New England Journal of Medicine 2012, 366:1190-1199.
29. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
30. Metawi S.A., Abbas D., Kamal M.M., Ibrahim M.K. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clinical Rheumatology 2011, 30:1201-1207.
31. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. New England Journal of Medicine 2009, 361:888-898.
32. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 1989, 7:145-173.
33. Mourao-Sa D., Robinson M.J., Zelenay S., Sancho D., Chakravarty P., Larsen R., Plantinga M., Van Rooijen N., Soares M.P., Lambrecht B., Reis e Sousa C. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. European Journal of Immunology 2011, 41:3040-3053.
34. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. Journal of Immunology 2003, 171:6173-6177.
35. Nistala K., Moncrieffe H., Newton K.R., Varsani H., Hunter P., Wedderburn L.R. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis and Rheumatism 2008, 58:875-887.
36. Papp K.A., Leonardi C., Menter A., Ortonne J.P., Krueger J.G., Kricorian G., Aras G., Li J., Russell C.B., Thompson E.H., Baumgartner S. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. New England Journal of Medicine 2012, 366:1181-1189.
37. Peters A., Pitcher L.A., Sullivan J.M., Mitsdoerffer M., Acton S.E., Franz B., Wucherpfennig K., Turley S., Carroll M.C., Sobel R.A., Bettelli E., Kuchroo V.K. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 2011, 35:986-996.
38. Poggi A., Canevali P., Contatore M., Ciprandi G. Higher frequencies of CD161 circulating T lymphocytes in allergic rhinitis patients compared to healthy donors. International Archives of Allergy and Immunology 2012, 158:151-156.
39. Read S., Powrie F. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Current Protocols in Immunology 2001, (Chapter 15, Unit 15.13). J.E. Coligan (Ed.).
40. Saijo S., Ikeda S., Yamabe K., Kakuta S., Ishigame H., Akitsu A., Fujikado N., Kusaka T., Kubo S., Chung S.H., Komatsu R., Miura N., Adachi Y., Ohno N., Shibuya K., Yamamoto N., Kawakami K., Yamasaki S., Saito T., Akira S., Iwakura Y. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010, 32:681-691.
41. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., Sakihama T., Matsutani T., Negishi I., Nakatsuru S., Sakaguchi S. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460.
42. Schacht V., Ramirez M.I., Hong Y.K., Hirakawa S., Feng D., Harvey N., Williams M., Dvorak A.M., Dvorak H.F., Oliver G., Detmar M. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO Journal 2003, 22:3546-3556.
43. Solpov A., Shenkman B., Vitkovsky Y., Brill G., Koltakov A., Farzam N., Varon D., Bank I., Savion N. Platelets enhance CD4+ lymphocyte adhesion to extracellular matrix under flow conditions: role of platelet aggregation, integrins, and non-integrin receptors. Thrombosis and Haemostasis 2006, 95:815-821.
44. Stromnes I.M., Goverman J.M. Active induction of experimental allergic encephalomyelitis. Nature Protocols 2006, 1:1810-1819.
45. Suzuki-Inoue K., Inoue O., Ozaki Y. Novel platelet activation receptor CLEC-2: from discovery to prospects. Journal of Thrombosis and Haemostasis 2011, 1(9 Suppl.):44-55.
46. Suzuki-Inoue K., Kato Y., Inoue O., Kaneko M.K., Mishima K., Yatomi Y., Yamazaki Y., Narimatsu H., Ozaki Y. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. Journal of Biological Chemistry 2007, 282:25993-26001.
47. Uhrin P., Zaujec J., Breuss J.M., Olcaydu D., Chrenek P., Stockinger H., Fuertbauer E., Moser M., Haiko P., Fassler R., Alitalo K., Binder B.R., Kerjaschki D. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010, 115:3997-4005.
48. van Beelen A.J., Teunissen M.B., Kapsenberg M.L., de Jong E.C. Interleukin-17 in inflammatory skin disorders. Current Opinion in Allergy and Clinical Immunology 2007, 7:374-381.
49. van den Berg W.B., Miossec P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nature Reviews 2009, 5:549-553.
50. Waite J.C., Skokos D. Th17 response and inflammatory autoimmune diseases. International Journal of Inflammation 2012, 2012:819467.
51. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunology 2007, 8:950-957.
52. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., Oliver P., Huang W., Zhang P., Zhang J., Shellito J.E., Bagby G.J., Nelson S., Charrier K., Peschon J.J., Kolls J.K. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. Journal of Experimental Medicine 2001, 194:519-527.
53. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 2007, 8:967-974.
54. Zielinski C.E., Mele F., Aschenbrenner D., Jarrossay D., Ronchi F., Gattorno M., Monticelli S., Lanzavecchia A., Sallusto F. Pathogen-induced human T(H)17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012, 484:514-518.